Abstract:Editorial Office Annals of Translational Medicine Submitted Oct 14, 2023. Accepted for publication Jan 15, 2024. Published online Apr 09, 2024. doi: 10.21037/atm-2023-22 Erratum to: Ann Transl Med 2021;9:663. This article (1) titled "Activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis" (doi: 10.21037/atm-21-1215), unfortunately, contains errors in Figure 5 and its legend, the citation of Figure 5 in the Results section and misuse of the word "mice" or "mouse" in the article. Corrections are presented below. Corrected Figure 5 and its legend In the section of Results Observation of serum and subchondral bone immunity in rat OA model HE staining observation should be corrected as follows: In normal rat, the subchondral bone cells of the knee joint were arranged in an orderly manner, number was normal, there was no fibrous tissue proliferation, and none or occasional infiltration of lymphocytes and monocytes ( Figure 5A ). In the 2-week model rat, the arrangement of knee joint subchondral osteocytes was slightly disordered, and a small amount of fibrous tissue was occasionally infiltrated with lymphocytes and monocytes ( Figure 5B ). In the 4-week model rat, knee joint subchondral osteocytes were reduced, cell arrangement was disordered, fibrous tissue formation could be seen, and some lymphocytes and monocyte infiltration were apparent ( Figure 5C ). In the 6-week model rat, knee joint subchondral bone cells were significantly reduced, cell arrangement was disordered, fibrous tissue was more than that of 4-week model rat, lymphocyte and monocyte infiltration was visibly greater than in the 4-week model rat ( Figure 5D ). In the 8-week model rat, the knee joint subchondral bone cells were significantly reduced, the cell arrangement was disordered, there was more fibrous tissue proliferation, and more visible infiltration of lymphocytes and monocytes ( Figure 5E ). Furthermore, the word "mice" or "mouse" presented in this article should be changed to "rat". The authors apologize for the oversight. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

[Corrigendum] Inhibition of RANKL‑induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium‑particle‑induced osteolysis.

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

[Corrigendum] Anti‐osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

[Corrigendum] Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF‐1 pathway inhibition in vivo

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway

[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‐negative breast cancer through the regulation of pyroptosis

Erratum to activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis

Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population: Erratum

[Corrigendum] Celecoxib inhibits the epithelial‐to‐mesenchymal transition in bladder cancer via the miRNA‐145/TGFBR2/Smad3 axis

[Corrigendum] Exogenous Hydrogen Sulfide Exerts Proliferation, Anti-Apoptosis, Migration Effects and Accelerates Cell Cycle Progression in Multiple Myeloma Cells Via Activating the Akt Pathway

[Corrigendum] Resveratrol reverses P‐glycoprotein‐mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‐κB and p38 MAPK signaling pathways

[Corrigendum] Lapatinib‑induced Inhibition of Ovarian Function is Counteracted by the STAT3 Pathway Both in Vivo and in Vitro

Preventing Tumor Progression to the Bone by Induced Tumor-Suppressing MSCs: Erratum

Plumbagin Attenuates Cancer Cell Growth and Osteoclast Formation in the Bone Microenvironment of Mice

Corrigendum: Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Correction: Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway

Autophagy Maintains the Function of Bone Marrow Mesenchymal Stem Cells to Prevent Estrogen Deficiency-Induced Osteoporosis: Erratum